Acute coronary syndromes in the elderly
Zenon S Kyriakides1, Spyros Kourouklis, Konstantinos Kontaras
12nd Department of Cardiology, Hellenic Red Cross Hospital, Athens, Greece. zskyr@otenet.gr
Elderly patients with acute coronary syndromes (ACS) often have worse outcomes and require tailored treatments. Invasive strategies like angioplasty are generally preferred over fibrinolysis for ST-segment elevation myocardial infarction (STEMI) in this population.
Area of Science:
- Cardiology
- Geriatric Medicine
- Internal Medicine
Background:
- Elderly patients represent a growing demographic for acute coronary syndromes (ACS).
- This population often presents with complex comorbidities, leading to poorer outcomes compared to younger patients.
- Elderly individuals are less likely to receive revascularization and evidence-based medications.
Purpose of the Study:
- To review the specific challenges and optimal management strategies for acute coronary syndromes (ACS) in the elderly.
- To highlight the importance of considering physiological age over chronological age in treatment decisions for older ACS patients.
Main Methods:
- Review of existing literature and clinical trial data concerning ACS management in elderly populations.
- Analysis of treatment efficacy and safety profiles of various interventions, including angioplasty, fibrinolysis, and stenting.
Main Results:
- Non-ST-segment elevation myocardial infarction (NSTEMI) is common and associated with high mortality in the elderly.
- Early invasive treatment is recommended for elderly patients with NSTEMI and unstable angina.
- Primary angioplasty appears more effective than fibrinolysis for ST-segment elevation myocardial infarction (STEMI) in the elderly, with drug-eluting stents showing greater benefit and cost-effectiveness.
- Low-molecular-weight heparin may be superior to unfractionated heparin post-fibrinolysis, but carries a higher bleeding risk, especially in older women.
Conclusions:
- Treatment decisions for elderly ACS patients should prioritize physiological age and comorbidities over chronological age.
- Angioplasty should be preferred for STEMI in the elderly when feasible, though further trials are needed.
- Careful consideration of bleeding risks is crucial when selecting antithrombotic therapies in this demographic.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
06:39Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
